Literature DB >> 8727167

Impaired awareness of deficits in Alzheimer disease.

B R Ott1, G Lafleche, W M Whelihan, G W Buongiorno, M S Albert, B S Fogel.   

Abstract

This study examined the relation between awareness of memory and functional decline and cognitive function in patients with Alzheimer disease (AD). Twenty-six patients with early AD and 16 nondemented elderly controls were studied. Awareness of deficits was determined by using (a) a discrepancy score between subject's and caregiver's ratings on a memory questionnaire, (b) a discrepancy score between subject's and caregiver's ratings on an activities-of-daily-living scale, and (c) a clinical rating of dementia awareness for patients. Whereas self-ratings of memory and activities of daily living were not significantly different between AD patients and controls, these two measures differed significantly when AD patients' ratings were compared with those of their caregivers. Measures of awareness of deficits correlated with one another and were primarily associated with performance on tests of executive and visuospatial functions but not with depression. Early AD is characterized by a failure of self-monitoring. Deficits in self-monitoring have been proposed to occur after damage to the frontal lobes and other cerebral areas. Impaired awareness of memory and functional deficits in AD is related to cognitive impairments, which may involve frontal and right hemisphere connections.

Entities:  

Mesh:

Year:  1996        PMID: 8727167     DOI: 10.1097/00002093-199601020-00003

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  43 in total

1.  A single-photon emission computed tomography imaging study of driving impairment in patients with Alzheimer's disease.

Authors:  B R Ott; W C Heindel; W M Whelihan; M D Caron; A L Piatt; R B Noto
Journal:  Dement Geriatr Cogn Disord       Date:  2000 May-Jun       Impact factor: 2.959

2.  Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease.

Authors:  G A Marshall; D I Kaufer; O L Lopez; G R Rao; R L Hamilton; S T DeKosky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

3.  Loss of emotional insight in behavioral variant frontotemporal dementia or "frontal anosodiaphoria".

Authors:  Mario F Mendez; Jill S Shapira
Journal:  Conscious Cogn       Date:  2011-09-29

4.  Prediction of on-road driving performance in patients with early Alzheimer's disease.

Authors:  Laura B Brown; Brian R Ott; George D Papandonatos; Yunxia Sui; Rebecca E Ready; John C Morris
Journal:  J Am Geriatr Soc       Date:  2005-01       Impact factor: 5.562

5.  Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease.

Authors:  Eric Salmon; Daniela Perani; Karl Herholz; Patricia Marique; Elke Kalbe; Vjera Holthoff; Xavier Delbeuck; Bettina Beuthien-Baumann; Oriana Pelati; Solange Lespagnard; Fabienne Collette; Gaëtan Garraux
Journal:  Hum Brain Mapp       Date:  2006-07       Impact factor: 5.038

6.  A diagnostic formulation for anosognosia in Alzheimer's disease.

Authors:  S E Starkstein; R Jorge; R Mizrahi; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

Review 7.  The role of cognitive control in cocaine dependence.

Authors:  Hugh Garavan; Robert Hester
Journal:  Neuropsychol Rev       Date:  2007-08-07       Impact factor: 7.444

Review 8.  Disorders of awareness in neuropsychiatric syndromes: an update.

Authors:  Laura A Flashman
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

9.  Cognitive correlates of metamemory in Alzheimer's disease.

Authors:  Danielle Shaked; Meagan Farrell; Edward Huey; Janet Metcalfe; Sarah Cines; Jason Karlawish; Elizabeth Sullo; Stephanie Cosentino
Journal:  Neuropsychology       Date:  2014-05-12       Impact factor: 3.295

10.  Standardised measurement of self-awareness deficits in FTD and AD.

Authors:  Craig Williamson; Oscar Alcantar; Johannes Rothlind; Deborah Cahn-Weiner; Bruce L Miller; Howard J Rosen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.